| The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against Gram‐negative bacteria in combination with EDTA treatment LA Martin‐Visscher, S Yoganathan, CS Sit, CT Lohans, JC Vederas FEMS microbiology letters 317 (2), 152-159, 2011 | 130 | 2011 |
| Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates CS Sit, S Yoganathan, JC Vederas Accounts of Chemical Research 44 (4), 261-268, 2011 | 99 | 2011 |
| N-Methylimidazole-catalyzed Synthesis of Carbamates from Hydroxamic Acids via the Lossen Rearrangement S Yoganathan, SJ Miller Organic letters 15 (3), 602-605, 2013 | 72 | 2013 |
| Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: A catalysis-based approach to combat glycopeptide-resistant pathogens S Yoganathan, SJ Miller Journal of medicinal chemistry 58 (5), 2367-2377, 2015 | 70 | 2015 |
| Chemical synthesis and biological evaluation of gallidermin-siderophore conjugates S Yoganathan, CS Sit, JC Vederas Organic & Biomolecular Chemistry 9 (7), 2133-2141, 2011 | 70 | 2011 |
| Synthesis and in vitro evaluation of 18F-and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studies KJ Guenther, S Yoganathan, R Garofalo, T Kawabata, T Strack, R Labiris, ... Journal of medicinal chemistry 49 (4), 1466-1474, 2006 | 52 | 2006 |
| Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment NS Kulkarni, V Parvathaneni, SK Shukla, L Barasa, JC Perron, ... European Journal of Pharmaceutical Sciences 133, 145-159, 2019 | 51 | 2019 |
| Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer S Yoganathan, A Alagaratnam, N Acharekar, J Kong Cells 10 (2), 458, 2021 | 35 | 2021 |
| Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates P Gupta, HL Gao, YV Ashar, NM Karadkhelkar, S Yoganathan, ZS Chen International Journal of Molecular Sciences 20 (2), 268, 2019 | 30 | 2019 |
| Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors X Shao, A AbdelKhalek, NS Abutaleb, UK Velagapudi, S Yoganathan, ... Journal of medicinal chemistry 62 (21), 9772-9791, 2019 | 24 | 2019 |
| Evaluation of copper (I)-doped zinc oxide composite nanoparticles on both gram-negative and gram-positive bacteria J Kong, S Zhang, M Shen, J Zhang, S Yoganathan Colloids and Surfaces A: Physicochemical and Engineering Aspects 643, 128742, 2022 | 17 | 2022 |
| Synthesis of N-1′, N-3′-disubstituted spirohydantoins and their anticonvulsant activities in pilocarpine model of temporal lobe epilepsy C Yang, FAX Schanne, S Yoganathan, RA Stephani Bioorganic & medicinal chemistry letters 26 (12), 2912-2914, 2016 | 17 | 2016 |
| An efficient one-pot conversion of carboxylic acids into benzimidazoles via an HBTU-promoted methodology L Barasa, S Yoganathan RSC Advances 8 (62), 35824-35830, 2018 | 15 | 2018 |
| Exploration of antibiotic activity of aminoglycosides, in particular ribostamycin alone and in combination with ethylenediaminetetraacetic acid against pathogenic bacteria J Kong, ZX Wu, L Wei, ZS Chen, S Yoganathan Frontiers in microbiology 11, 1718, 2020 | 13 | 2020 |
| Repurposing N, N-Dimethylacetamide (DMA), a Pharmaceutical Excipient, as a Prototype Novel Anti-inflammatory Agent for the Prevention and/or Treatment of Preterm Birth S Gorasiya, J Mushi, R Pekson, S Yoganathan, SE Reznik Current pharmaceutical design 24 (9), 989-992, 2018 | 13 | 2018 |
| Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia P Gupta, GN Zhang, AM Barbuti, X Zhang, N Karadkhelkar, J Zhou, ... Cancer Letters 472, 132-141, 2020 | 12 | 2020 |
| An efficient chemical synthesis of carboxylate-isostere analogs of daptomycin S Yoganathan, N Yin, Y He, M Mesleh, YG Gu, SJ Miller Org. Biomol. Chem. 11, 4680-4685, 2013 | 11 | 2013 |
| Fracturing rings to understand lantibiotics S Yoganathan, JC Vederas Chemistry & biology 15 (10), 999-1001, 2008 | 10 | 2008 |
| MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo study ZX Wu, QX Teng, Y Yang, N Acharekar, JQ Wang, M He, S Yoganathan, ... Acta Pharmaceutica Sinica B 12 (5), 2609-2618, 2022 | 8 | 2022 |
| Development of an Arginine Anchored Nanoglobule with Retrograde Trafficking Inhibitor (Retro-2) for the Treatment of an Enterohemorrhagic Escherichia coli Outbreak T Gandhi, M Patki, J Kong, J Koya, S Yoganathan, S Reznik, K Patel Molecular pharmaceutics 16 (10), 4405-4415, 2019 | 6 | 2019 |
Clarissa SitSaint Mary's UniversityVerified email at smu.ca
